Search

Your search keyword '"Felix, Fulde"' showing total 2 results
Start Over Author "Felix, Fulde"
2 results on '"Felix, Fulde"'

1. Optimized Implantation Height of the Edwards SAPIEN 3 Valve to Minimize Pacemaker Implantation After TAVI

Author

Henryk Dreger, Felix Fulde, Wolfram C. Poller, Marius Schwerg, Michael Laule, and Karl Stangl

Subjects
medicine.medical_specialty, Transcatheter aortic, business.industry, Treatment outcome, 030204 cardiovascular system & hematology, Pacemaker implantation, Surgery, 03 medical and health sciences, 0302 clinical medicine, Paravalvular leakage, Cuff, Medicine, Radiology, Nuclear Medicine and imaging, In patient, 030212 general & internal medicine, Permanent pacemaker, Cardiology and Cardiovascular Medicine, business, Edwards sapien
Abstract

Aim The transcatheter aortic valve SAPIEN 3 aims at reducing paravalvular leakage (PVL). The new design with outer sealing cuff may increase the risk of permanent pacemaker implantation (PPM). The aim of our study was to evaluate the optimal implantation height of the SAPIEN 3. Methods and Results We analysed the correlation between the implantation height of the valve and the need for PPM in 131 patients. The PPM rate for the entire group after TAVI was 18% (n = 24). In patients with a marker distance

Published
2016
Full Text
View/download PDF

2. Optimized Implantation Height of the Edwards SAPIEN 3 Valve to Minimize Pacemaker Implantation After TAVI

Author

Marius, Schwerg, Felix, Fulde, Henryk, Dreger, Wolfram C, Poller, Karl, Stangl, and Michael, Laule

Subjects
Aged, 80 and over, Male, Pacemaker, Artificial, Aortic Valve Stenosis, Prosthesis Design, Equipment Failure Analysis, Transcatheter Aortic Valve Replacement, Postoperative Complications, Treatment Outcome, Aortic Valve, Germany, Heart Valve Prosthesis, Prosthesis Fitting, Humans, Female, Aged
Abstract

The transcatheter aortic valve SAPIEN 3 aims at reducing paravalvular leakage (PVL). The new design with outer sealing cuff may increase the risk of permanent pacemaker implantation (PPM). The aim of our study was to evaluate the optimal implantation height of the SAPIEN 3.We analysed the correlation between the implantation height of the valve and the need for PPM in 131 patients. The PPM rate for the entire group after TAVI was 18% (n = 24). In patients with a marker distance2 mm ("low implantation"), the PPM rate was 32%, whereas in patients with a distance ≥2 mm ("high implantation"), the rate was only 4.7% (OR of 0.1 (0.03-0.37, P 0.001)).The risk of periprocedural PPM with the Edwards SAPIEN 3 depends on implantation height; it is increased when using conventional implantation techniques. This risk can be minimized below 5% PPM by choosing a higher implantation technique with the central marker 2 mm or more over the annulus plane.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results